Axitinib + Ipilimumab in Advanced Melanoma
Clinical trial NCT04996823 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04996823
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-04
- Primary completion
- 2026-08-20
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.